NCT01804231View on ClinicalTrials.gov

Prospective Study Using Hybrid PET/MRI to Evaluate Men With Suspected Recurrence Following Treatment for Prostate Cancer

NACompletedINTERVENTIONAL
Enrollment

22

Participants

Timeline

Start Date

July 9, 2013

Primary Completion Date

December 15, 2015

Study Completion Date

October 12, 2016

Conditions
Prostate Cancer
Interventions
OTHER

18F-FCH PET/MRI imaging

Patients will first undergo screening to ensure eligibility. If eligible, they will undergo one scan in a Hybrid PET/MRI scanner using 18F-FCH as the radiolabeled tracer.

Trial Locations (1)

N6A 5W9

London Health Sciences Centre, London

All Listed Sponsors
collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

lead

London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's

OTHER

NCT01804231 - Prospective Study Using Hybrid PET/MRI to Evaluate Men With Suspected Recurrence Following Treatment for Prostate Cancer | Biotech Hunter | Biotech Hunter